Table 1 Demographic and clinical characteristics
Variable | No. of patients (%) |
|---|---|
Age (years) (n = 51) | |
21–40 | 4 (7.8) |
41–60 | 11 (21.6) |
61–80 | 34 (66.7) |
81–90 | 2 (3.9) |
Gender (n = 51) | |
Male | 25 (49.0) |
Female | 26 (51.0) |
Type of drugs (n = 64) | |
conbercept | 48 (73.8) |
aflibercept | 16 (24.6) |
Diagnoses (n = 51) | |
nAMD | 23 (45.1) |
DME | 18 (35.3) |
CME/BRVO | 5 (9.8) |
VH/DR | 3 (5.9) |
CNV | 1 (2.0) |
CME/CRVO | 1 (2.0) |
Diabetic (n = 51) | |
Yes | 24 (47.1) |
No | 27 (52.9) |
Pseudophakic (n = 51) | |
Yes | 13 (25.5) |
No | 38 (74.5) |